跳至主要内容
临床试验/NCT06040333
NCT06040333已完成不适用

The Effect of Dynamic Neuromuscular Stabilization Training in Dysfunctional Voiding : A Randomized Clinical Trial

Halic University1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2021年3月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
1
主要终点
Uroflowmetry - Voiding volume (VV)

研究概览

简要总结

In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Uroflowmetry, Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form were applied to all participants at baseline and at week 6.

详细描述

In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. This experimental study was conducted with patients who applied to UroKlinik in Istanbul between March 2021 and June 2023 and were diagnosed with dysfunctional voiding. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form and Uroflowmetry test were applied to all participants before and at week 6.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Having been diagnosed with dysfunctional voiding,
  • Being between the ages of 18-75,
  • Not having a neurogenic bladder
  • Not having a urinary tract infection
  • Not having an obstacle to exercise,
  • Accepting and signing the Approval Form,
  • Not having undergone surgery in the last 6 months,

排除标准

  • Not being cooperative
  • Not being able to participate in the treatment,
  • The use of drugs that will affect urination

结局指标

主要结局

Uroflowmetry - Voiding volume (VV)

时间窗: at the baseline and at week 6.

Uroflowmetry gives information about urine flow rate and voiding pattern. \*VV (ml): VV indicates the amount of voiding.

Short Form 36

时间窗: at the baseline and at week 6.

It gives information about health related quality of life. The total score of the scale ranges from 0 to 100, and a high score indicates a high quality of life.

Uroflowmetry - Corrected maximum flow rate (cQmax)

时间窗: at the baseline and at week 6.

Uroflowmetry gives information about urine flow rate and voiding pattern. \*cQmax (mL/s/√ mL): cQmax is the precise assessment of fastest stream, especially at high volumes. Is it estimated Qmax/√ VV.

Uroflowmetry - Maximum flow rate (Qmax)

时间窗: at the baseline and at week 6.

Uroflowmetry gives information about urine flow rate and voiding pattern. \*Qmax (mL/s): Qmax is the fastest stream measured in mL/s.

Uroflowmetry - Average flow rate (Qave)

时间窗: at the baseline and at week 6.

Uroflowmetry gives information about urine flow rate and voiding pattern. \*Qave (mL/s): Qave is the average stream measured in mL/s.

Uroflowmetry - Flow time (FT)

时间窗: at the baseline and at week 6.

Uroflowmetry gives information about urine flow rate and voiding pattern. \*FT (s): FT is the time over which measurable flow actually occurs.

Uroflowmetry - Residual urine (RU)

时间窗: at the baseline and at week 6.

Uroflowmetry gives information about urine flow rate and voiding pattern. \*RU (ml): RU is the amount of urine that is left behind in the bladder after you are done urinating.

Dysfunctional Voiding and Incontinence Symptom Score

时间窗: at the baseline and at week 6.

It gives information about voiding and incontinence symptoms. The questionnaire contains fourteen questions about symptoms and quality of life. The total score ranges from 0 to 35 and a score above 8.5 indicates abnormalities.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Duygu Şahin Altaç

Principal investigator, MSc, PT

Halic University

研究点 (1)

Loading locations...

相似试验